Correlation Between Mallinckrodt Plc and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Mallinckrodt Plc and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mallinckrodt Plc and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mallinckrodt Plc and Petros Pharmaceuticals, you can compare the effects of market volatilities on Mallinckrodt Plc and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mallinckrodt Plc with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mallinckrodt Plc and Petros Pharmaceuticals.

Diversification Opportunities for Mallinckrodt Plc and Petros Pharmaceuticals

0.42

Correlation Coefficient

Mallinckrodt Plc  Petros Pharmaceuticals

Very weak diversification

The 3 months correlation between Mallinckrodt and Petros is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mallinckrodt Plc and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Mallinckrodt Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mallinckrodt Plc are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Mallinckrodt Plc i.e., Mallinckrodt Plc and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Mallinckrodt Plc and Petros Pharmaceuticals

Considering the 90-day investment horizon Mallinckrodt Plc is expected to generate 2.15 times more return on investment than Petros Pharmaceuticals. However, Mallinckrodt Plc is 2.15 times more volatile than Petros Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  939.00  in Mallinckrodt Plc on September 3, 2024 and sell it today you would lose (893.00) from holding Mallinckrodt Plc or give up 95.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	30.91%
Values	Daily Returns

Mallinckrodt Plc  vs.  Petros Pharmaceuticals

Mallinckrodt Plc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mallinckrodt Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Mallinckrodt Plc is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Petros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Mallinckrodt Plc and Petros Pharmaceuticals

The main advantage of trading using opposite Mallinckrodt Plc and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mallinckrodt Plc position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind Mallinckrodt Plc and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.